[Federal Register Volume 87, Number 165 (Friday, August 26, 2022)]
[Notices]
[Pages 52505-52506]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-18470]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-37-2022]


Foreign-Trade Zone (FTZ) 35--Philadelphia, Pennsylvania, 
Notification of Proposed Production Activity, Piramal Pharma Solutions 
(Pharmaceutical Products), Sellersville, Pennsylvania

    Piramal Pharma Solutions submitted a notification of proposed 
production activity to the FTZ Board (the Board) for its facility in 
Sellersville, Pennsylvania under FTZ 35. The notification conforming to 
the requirements of the Board's regulations (15 CFR 400.22) was 
received on August 19, 2022.
    Pursuant to 15 CFR 400.14(b), FTZ production activity would be 
limited to the specific foreign-status material(s)/component(s) and 
specific finished product(s) described in the submitted notification 
(summarized below) and subsequently authorized by the Board. The 
benefits that may stem from conducting production activity under FTZ 
procedures are explained in the background section of the Board's 
website--accessible via www.trade.gov/ftz.
    The proposed finished products are bempedoic acid and ezetimibe 
tablets (180/10 milligrams) (duty-free).
    The proposed foreign-status materials are bempedoic acid and 
ezetimibe (duty rate ranges from 4% to 6.5%). The request indicates 
that the materials are subject to duties under Section 301 of the Trade 
Act of 1974 (section 301), depending on the country of origin. The 
applicable Section 301 decisions require subject merchandise to be 
admitted to FTZs in privileged foreign status (19 CFR 146.41).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive

[[Page 52506]]

Secretary and sent to: [email protected]. The closing period for their 
receipt is October 5, 2022.
    A copy of the notification will be available for public inspection 
in the ``Online FTZ Information System'' section of the Board's 
website.
    For further information, contact Christopher Wedderburn at 
[email protected].

    Dated: August 23, 2022.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2022-18470 Filed 8-25-22; 8:45 am]
BILLING CODE 3510-DS-P